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Inactivation of both cytosolic 5 ’ -nucleotidase and ecto-5 ’ -nucleotidase bydiethylpyrocarbonate indicated 
the presence of an essential histidyl residue which in the cytosolic enzyme was conclusively ocated at the 
active site. Inactivation by thiol reagents indicated the presence of an essential cysteinyl residue in both 
enzymes. The data suggest that both 5’-nucleotidases belong to a group of histidine phosphatases which 
also includes glucose-6-phosphatase nd acid phosphatase. A working hypothesis for the catalytic 
mechanism of these enzymes i  proposed. 
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1. INTRODUCTION 
The cytoplasmic 5 ‘-nucleotidase is the rate- 
limiting enzyme controlling loss of cellular adenine 
nucleotides during energy depletion [ 11. The activi- 
ty of the enzyme also determines the rate of forma- 
tion from cytosolic AMP of the regulatory 
metabolite adenosine [2,3]. Adenosine subsequent- 
ly acts to ameliorate or reverse the energy im- 
balance [4]. The plasma membrane 5 ’ nucleo- 
tidase is an ecto-enzyme [5] which may participate 
in the repletion of intracellular purine nucleotides 
by facilitating the incorporation of the nucleoside 
moiety from extracellular AMP [6,7]. The ecto- 
enzyme may also generate adenosine from extra- 
cellular nucleotides [8]. 
gations using group specific reagents to identify 
the residues essential for catalysis by the cytosolic 
enzyme and to establish similarities with the ecto- 
5 ’ nucleotidase. 
2. EXPERIMENTAL 
2.1. Materials 
We have demonstrated using enzyme kinetic 
studies [9] that the catalytic mechanism of the 
cytosolic 5 ’ -nucleotidase involves a phosphory- 
lated enzyme intermediate. We report here investi- 
Diethylpyrocarbonate (DEPC), iodoacetamide, 
N-ethylmaleimide (NEM), 5 ’ -p-fluorosulphonyl- 
benzoyladenosine (5 ‘FSBA), phenylmethylsul- 
phonylfluoride (PMSF), N-acetylimidazole (NAI), 
methylmethanethiosulphonate (MMTS), and 
diisopropylfluorophosphate (DFP) were obtained 
from Sigma. Hydroxylamine was obtained from 
Aldrich and mercaptoethanol from BDH. 
2.2. Enzymes 
+ TO whom correspondence should be addressed at: 
Department of Cardiology, Welsh National School of 
Medicine, Heath Park, Cardiff CF4 4XN, Wales 
Rat liver cytosolic 5 ’ nucleotidase (spec. act. 
4-6 umts/mg protein) was prepared by an ab- 
breviation of the procedure in [lo] as described in 
[9]. Rat liver plasma membrane 5 ‘-nucleotidase 
(spec. act. 36 units/mg) was prepared as in [ll]. 
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2.3. Conditions for inhibition and reactivation 
Cytosolic 5 ’ -nucleotidase (final concentration 
0.2-0.5 units/ml) was incubated with 5 mM 
Tes-NaOH, 25 mM sodium &glycerophosphate 
(pH 7.4), 100 mM NaCl, 0.5 mM EDTA and in- 
hibitors or reactivators at concentrations hown in 
the text. DEPC was dissolved at 20-times the final 
concentration in ethanol. 5 ’ FSBA was dissolved to 
8 mM in ethanol-dimethylformamide (1: 1, v/v). 
In these cases control incubations containing vehi- 
cle but no inhibitor were conducted and the activi- 
ty of inhibited or reactivated enzyme related to this 
control. Other inhibitors were added from aqueous 
solutions containing 50 mM sodium fi-glycero- 
phosphate (pH 7.4). Incubations were conducted 
for periods and at temperatures hown in the text 
and then terminated by dilution IO-fold into the 
assay medium. In the case of DEPC reactions were 
quenched with 10 mM (final concentration) imida- 
zole-HCI (pH 7.4). Enzyme activity was determin- 
ed as in [3]. 
Plasma membrane 5 ’ -nucleotidase (final con- 
centration 0.2-0.5 units/ml) was incubated with 
10 mM Tes-NaOH (pH 7.4) 2 mM MgC12 and in- 
hibitors or reactivators added from stock solutions 
dissolved in the same buffer. DEPC was added as 
mentioned above. Enzyme activity was determined 
as in [ll]. 
3. RESULTS 
3.1. Inactivation of 5 ‘-nucleotidase byDEPC 
The cytosolic and plasma membrane 
5 ’ -nucleotidases were both rapidly inactivated by 
DEPC (fig.l). The cytoplasmic enzyme was more 
susceptible. Inactivation of the cytosolic enzyme 
was initially a first-order process (fig.2a) and the 
apparent rate constant (ki) was obtained at a series 
of DEPC concentrations. A plot [12] of 1Ogki vs 
log(concentration of DEPC) was linear with a 
slope of 0.84 f 0.06 (mean + SE, 5 degrees of 
freedom) (fig.2b). This value was close to unity 
and demonstrated that modification of a single 
residue inactivated the enzyme. 
DEPC can modify lysyl, histidyl, cysteinyl, seryl 
and tyrosyl residues of proteins [ 131. Modification 
of histidine and serine is rapidly reversible by 
NH2OH [ 131 whilst modification of tyrosine is 
more resistant to reversal [13]. Modification of 
lysine and cystine is irreversible by NHzOH [13]. 
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Fig. 1. Inactivation and reactivation of 5 ’ -nucleotidase. 
Cytosolic 5 ‘-nucleotidase (0) or plasma membrane 
5 ‘-nucleotidase (0) was incubated with various 
concentrations of DEPC for 15 min at 23°C. The 
reaction was terminated with 10 mM imidazole-HCl 
(pH 7.4) and the remaining activity then determined. 
Cytosolic enzyme so treated with 0.2 mM DEPC (A) or 
plasma membrane enzyme treated with 1 mM DEPC (A) 
was incubated for 1 h at 37’C with various 
concentrations of NHlOH and then activity determined. 
Values are means from two experiments each conducted 
in triplicate. 
The inhibition of the cytosolic 5 ’ -nucleotidase by 
DEPC was readily and completely reversed by 
NHzOH (fig.1). Reactivation of the plasma mem- 
brane enzyme was also readily achieved but was 
only partial. Reactivation was not improved by in- 
cubation with 100 mM NHzOH for up to 3 h. 
The ease of reactivation by NHzOH argued 
against the participation of lysine, cysteine or 
tyrosine [13]. Further evidence against tyrosine 
was gained using NAI [ 141. Incubation of cytosolic 
5 ‘-nucleotidase with 20 mM NAI at 37°C for 
30 min followed by dialysis to remove NAI red- 
uced enzyme activity to 63 +- 5% (results from 4 ex- 
periments). However, since no reactivation was 
achieved after incubation with 100 mM NHzOH at 
37°C for 1 h (final activity 50 f 5%) the inactiva- 
tion could not be ascribed to modification of 
tyrosine [ 141. The plasma membrane 5 ’ -nucleoti- 
dase may be iodinated without loss of enzymatic 
activity [15] again arguing against the presence of 
an active site tyrosyl residue. 
Incubation of cytosolic 5 ’ -nucleotidase with 
1.25 mM DFP for 3 h at 37°C did not cause inhibi- 
tion (final activity 98 f 2% of control, 2 ex- 
periments). Incubation under the same conditions 
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Fig.2. Kinetics of inactivation of cytosolic 
5 ’ -nucleotidase byDEPC. (a) Cytosolic 5 ’ -nucleotidase 
was incubated at 23’C with 0.1 mM (0), 0.12 mM (e), 
0.2 mM (O), 0.4 mM (v), 0.6 mM (m), 0.8 mM (A) and 
1.0 mM (A) DEPC. At the times hown the reaction was 
quenched with 10 mM imidazole-HCl @H 7.4) and 
enzymatic activity determined. Values are means of two 
experiments each conducted in triplicate. (b) The slopes 
of the lines in (a) were used to determine the first-order 
rate constant ki. 
with 4 mM PMSF also failed to inhibit the 
cytosolic 5 ‘-nucleotidase (final activity 104 f 4%, 
3 experiments) or the plasma membrane 
5 ’ aucleotidase (final activity 106 + 4070, 2 ex- 
periments). These experiments demonstrated that 
5 ‘-nucleotidase is not a serine esterase [16]. 
In summary, the results eliminated all but 
histidyl residues as possible sites for reaction with 
DEPC. 
3.2. Protection against inactivation by DEPC 
Inactivation of the cytosolic 5 ’ -nucleotidase 
with 0.2 mM DEPC for 15 min at 23°C was red- 
uced from 99 f 1% to 75 + 9% in the presence of 
5 mM IMP but was not reduced in the presence of 
70 mM inosine. Inhibition was reduced to 12 f 1% 
in the presence of 3 mM IMP plus 70 mM inosine 
(results of 4 experiments). Time-course studies 
(fig.3) showed that the first-order rate constant for 
inactivation by 0.2 mM DEPC was reduced by 
3 mM IMP and 70 mM inosine from 0.198 to 
0.010 min-’ while that for inactivation by 1 mM 
DEPC was reduced from 0.792 to 0.038 min-‘. 
The synergistic effect of inosine and IMP indicated 
that they did not protect the enzyme by reacting 
with DEPC. 
Inactivation of the plasma membrane 
5 ’ -nucleotidase with 1 mM DEPC at 23°C for 
15 min was reduced from 91 f 1% to 77 + 1% in 
the presence of 2 mM AMP and to 75 + 2% in the 
presence of the competitive inhibitor ATP (2 mM). 
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Fig.3. Protection of cytosolic 5 ’ -nucleotidase from 
inhibition by DEPC. Cytosolic 5’nucleotidase was 
incubated with 0.2 mM DEPC (0, l ) or 1 mM DEPC 
(A, A) either in the presence (0, A) or absence (0, A) 
of 3 mM IMP and 70 mM inosine for 15 min at 37°C. 
Reaction was terminated with 10 mM imidazole-HCI 
(PH 7.4) and then enzyme activity was determined. 
Values are means from two experiments each performed 
in triplicate. 
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Table 1 
Effect of thiol reagents on 5 ’ -nucleotidase 
Enzyme Inhibitor Concentration Residual 
(mM) activity (070) 
Plasma membrane iodoacetamide 15 4 *l 
5 ’ -nucleotidase NEM 15 83 f 1 
cysteine 15 63 f 7 
I-&CL 5 12 f 1 
Cytosolic iodoacetamide 15 92 + 6 
5 ’ -nucleotidase NEM 12 95 f 8 
H8Clz 2 0.3 f 0.2 
5 ’ FSBA 1.25 60 f 20 
MMTS 10 95 -+ 4 
Carboxyethylated iodoacetamide 15 33 f 1 
cytosolic NEM 15 72 + 3 
5 ’ -nucleotidase 5 ’ FSBA 1.25 9 *4 
MMTS 10 46 f 3 
Cytosolic or plasma membrane 5’-nucleotidase was incubated with inhibitors 
for 15 min at 37’C before dilution by lo-fold into assay medium for 
measurement of enzymatic activity. Carboxyethylated cy-tosolic 5 ’-nucleotidase 
was produced by incubation with 0.2 mM DEPC for 15 min at 23°C followed 
by quenching with 10 mM imidazole-HCI (PH 7.4). After incubation with 
inhibitors the enzyme was reactivated with 50 mM NHzOH-HCl @H 7.4) for 
1 h at 37°C and activity determined. This condition completely reactivated the 
enzyme not treated with thiol reagents (fig. 1). Nonetheless, carboxyethylated- 
reactivated enzyme served as a control for these experiments. During use of 
5 ’ FSBA 75 + 5% inactivation was caused by the vehicle alone (results from 4 
experiments). Thus vehicle treated controls were used for these experiments. 
Each result is the mean (f SE) for at least 3 separate xperiments 
February 1984 
Adenosine (5 mM) did not enhance the protection 
conferred by AMP. 
3.3. Reaction with thiol reagents 
The plasma membrane 5 ’ -nucleotidase was in- 
hibited by iodoacetamide, NEM, cysteine and 
HgClz (table 1) all of which react with thiol groups 
[ 171. The inactivation on exposure to 15 mM 
iodoacetamide at 37°C for 15 min (96 f 1 s/o) was 
reduced to 53 f 1% by 5 mM ATP but was not 
reduced by 5 mM AMP. 
The cytosolic 5’ -nucleotidase was not inhibited 
by thiol reagents except HgClz (table 1). However, 
when the enzyme was treated first with DEPC and 
then with thiol reagents, the enzyme could no 
longer be fully reactivated by NHzOH (table 1). 
When reactivation of the enzyme treated with 
DEPC and the thiol reagent 5 ‘FSBA [18] was at- 
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tempted with 50 mM NHzOH only 9% of activity 
was recovered (table 1). This was improved to 60 
f 10% if reactivation was conducted with 50 mM 
NHzOH plus 10 mM mercaptoethanol. Thus reac- 
tion of the cytosolic 5 ’ -nucleotidase with DEPC 
exposed a susceptible cysteinyl residue. 
4. DISCUSSION 
4.1. Essential residues bf 5 ‘-nucleotidase 
Inactivation of both cytosolic and plasma mem- 
brane 5 ’ nucleotidase by DEPC and its ready 
reversal by NHzOH suggested the presence of an 
essential histidyl or seryl residue. Failure to inhibit 
the enzyme with inhibitors of serine esterases in- 
dicated that the residue modified by DEPC was a 
histidyl residue. Partial reactivation of the plasma 
membrane 5 ’ -nucleotidase could be explained by 
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the presence of a susceptible cysteinyl or lysyl 
residue in addition to the histidyl residue. The ex- 
periments with thiol reagents indicated that the 
plasma membrane (but not the cytosolic) 
5 ’ -nucleotidase possesses an accessible cysteinyl 
residue. Modification of this residue by the 
relatively high concentration of DEPC needed 
might explain the irreversible loss of activity. The 
cytosolic 5 ’ -nucleotidase possesses an essential 
cysteinyl residue which was revealed only after 
reaction of the enzyme with low concentrations of 
DEPC. 
4.2. Location of the essential residues 
The pH-activity profile of the cytosolic 
5 ’ -nucleotidase is consistent with the participation 
of both histidyl and cysteinyl residues in the 
catalytic mechanism [19]. A combination of IMP 
and inosine protected the cytosolic 5 ’ -nucleotidase 
from inhibition ‘by DEPC. These ligands induce 
the formation of an enzyme-phosphate-inosine 
complex [9] locating the susceptible histidyl residue 
at the active site. The poor protection conferred by 
IMP alone demonstrated that the phosphorylated 
enzyme remained reactive to DEPC (possibly at 
the unphosphorylated nitrogen of the histidine 
ring) unless access to the active site was sterically 
hindered by inosine. 
The inactivation of plasma membrane 
5 ’ nucleotidase, was only slightly decelerated in the 
presence of substrate. The failure of adenosine to 
inhibit plasma membrane 5 ’ -nucleotidase non- 
competitively [20,21] or to promote nucleoside ex- 
change [9,22] indicates that it has a low affinity for 
any postulated enzyme-phosphate intermediate. 
Therefore, additional protection of the enzyme 
from attack by DEPC was not expected. In addi- 
tion, DEPC may act at a second site. Thus location 
of the susceptible histidine to the active site of the 
plasma membrane 5 ’ -nucleotidase was suggestive 
but not conclusive. 
ATP protected the plasma membrane 
5 ’ -nucleotidase from inactivation by iodoaceta- 
mide implying the presence of an active site thiol 
group. ATP is a competitive inhibitor of this 
5’nucleotidase 120,211 and the enzyme does not 
display allosteric properties suggesting that ATP 
and substrates compete at the active site. However, 
substrate alone did not protect the enzyme. Whilst 
this might be due to the smaller size of AMP, it is 
not possible to rule out that ATP caused a confor- 
mational change or protected a residue outside the 
active site. Likewise, it is possible that reaction of 
the cytosolic 5’-nucleotidase with DEPC relieved 
an intramolecular interaction between histidine 
and cysteine at the active site. On the other hand 
carboxyethylation may have caused a gross confor- 
mational change which unmasked a cysteinyl 
residue. 
4.3. Comparison with other phosphatases 
A phospho-enzyme intermediate of the cytosolic 
5 ’ nucleotidase was detected by observing 
nucleoside exchange and from the kinetics of in- 
hibition by product, inosine [9]. Similar evidence 
has been presented for glucose-6-phosphatase [23]. 
Plasma membrane 5 ’ -nucleotidase was reported in 
[20] to catalyse a low rate of nucleoside exchange 
but nucleoside exchange was undetectable in 
[9,22]. Nucleoside exchange may be unfavourable 
with the ecto-enzyme owing to the low affinity of 
product for the putative phospho-enzyme in- 
termediate or due to its rapid hydrolysis. The turn- 
over number of the ecto-enzyme is approx. 
20-times that of the cytosolic 5 ’ -nucleotidase 
[lO,ll]. 
Both acid phosphatase [24] and glucosed-phos- 
phatase [25] can be phosphorylated by substrate on 
a histidyl residue. These enzymes also possess 
essential cysteinyl residues [26,27] although in 
neither case was inactivation by thiol reagents 
completely prevented by substrate. In contrast, 
alkaline phosphatase is a serine esterase which is 
inhibitable by DFP [ 161. Our results suggest hat 
the cytosolic and the ecto-5 ’nucleotidase belong 
to a group of histidine phosphatases. It will be in- 
teresting to study the evolutionary relation be- 
tween these enzymes. 
4.4. Catalytic mechanism 
A working hypothesis for the catalytic 
mechanism of the cytosolic 5 ’ -nucleotidase is 
shown in fig.4. Nucleophilic attack by histidine on 
IMP leads to an enzyme phosphate intermediate. 
The high pKa of the 5 ‘-OH of inosine implies that 
it would be a very poor leaving group unless aided 
by a general acid. Likewise, the uncatalysed 
hydrolysis of histidine phosphate is slow [28] im- 
plying the need for a general base to activate water 
or indeed inosine when it participates in the ex- 
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MODEL OF CATALYSIS 
Al---l-B' 
Fig.4. A working hypothesis for the catalytic mechanism 
of cytosolic 5 ’ nucleotidase. The working hypothesis 
attempts to account for: (1) the formation of a phospho- 
enzyme intermediate; (2) participation of an active site 
histidine; (3) the need for general acid/base catalysis, a
function which cysteine might perform; (4) the ability of 
Mg’+ to activate the enzyme [lo]. (A) The Michaelis 
complex of cytosolic S-nucleotidase and IMP. (B) Acid 
catalysed rupture of the bond between the inosine and 
phosphate moieties whilst establishing a partial covalent 
bond with the active site histidine. (C) Base catalysed 
collapse of the phosphorylated nzyme intermediate by 
water (HOH) or inosine. (D) The free enzyme. 
change reaction. This mechanism may be ap- 
plicable to the other histidine phosphatases. 
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